GENEVA, July 6 -- ZEVRA THERAPEUTICS, INC. filed a patent application (US2025/061056) for “METHODS OF TREATING LYSOSOMAL STORAGE DISORDERS USING ARIMOCLOMOL AND MIGLUSTAT PRODRUGS”. With publication no. WO/2026/143072, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07D 211/46
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....